Development and characterization of clarithromycin-smectite hybrid for burst release at high pH condition

Donghoon Chung, Young Goo Song, Il Mo Kang, Woohyun Choi, Changyun Park, Yun Goo Song

Research output: Contribution to journalArticle

Abstract

In this study, we developed and characterized a clarithromycin (CLR)-intercalated smectite hybrid and demonstrate that it holds great potential as an effective drug-carrier for local delivery of CLR. The intercalation of CLR into a smectite interlayer was examined at 0.4-4.0 mg ml -1 of CLR solution at pH 5. The developed CLR-intercalated smectite hybrid was characterized using x-ray diffraction (XRD), UV-vis spectroscopy, energy dispersive x-ray spectroscopy (EDS), thermogravimetric-differential thermal analysis (TG-DTA) and Fourier transform infrared spectroscopy (FT-IR). Intercalation of CLR was confirmed by an increase in the d-spacing in the XRD pattern and the ether absorbance band in the FT-IR spectrum for the CLR hybrid. An in vitro release study demonstrates that most of the CLR was released from the hybrid in both low pH condition (pH 1.2) and high pH condition (pH 7.4) fluids within 60 min. Compared with the conventional tablet form, approximately 4-times more CLR was released within 1 h at high pH conditions, indicating suitable local therapeutic performance. Therefore, Helicobacter pylori, which is located only in the gastric mucosal layer could be a good target organism for this hybrid. In conclusion, smectite could be a suitable carrier for local delivery of intercalated drug, and CLR intercalated smectite could be a new option for local therapy of gastrointestinal conditions.

Original languageEnglish
Article number115408
JournalMaterials Research Express
Volume5
Issue number11
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Clarithromycin
Intercalation
X rays
Fourier transform infrared spectroscopy
Ultraviolet spectroscopy
Differential thermal analysis
Diffraction patterns
Energy dispersive spectroscopy
Ethers
Diffraction
Spectroscopy
Fluids
Smectite
Drug Carriers
Ether
Tablets

All Science Journal Classification (ASJC) codes

  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Surfaces, Coatings and Films
  • Polymers and Plastics
  • Metals and Alloys

Cite this

Chung, Donghoon ; Song, Young Goo ; Kang, Il Mo ; Choi, Woohyun ; Park, Changyun ; Song, Yun Goo. / Development and characterization of clarithromycin-smectite hybrid for burst release at high pH condition. In: Materials Research Express. 2018 ; Vol. 5, No. 11.
@article{4f011b227d1847a2876ada4997d6d693,
title = "Development and characterization of clarithromycin-smectite hybrid for burst release at high pH condition",
abstract = "In this study, we developed and characterized a clarithromycin (CLR)-intercalated smectite hybrid and demonstrate that it holds great potential as an effective drug-carrier for local delivery of CLR. The intercalation of CLR into a smectite interlayer was examined at 0.4-4.0 mg ml -1 of CLR solution at pH 5. The developed CLR-intercalated smectite hybrid was characterized using x-ray diffraction (XRD), UV-vis spectroscopy, energy dispersive x-ray spectroscopy (EDS), thermogravimetric-differential thermal analysis (TG-DTA) and Fourier transform infrared spectroscopy (FT-IR). Intercalation of CLR was confirmed by an increase in the d-spacing in the XRD pattern and the ether absorbance band in the FT-IR spectrum for the CLR hybrid. An in vitro release study demonstrates that most of the CLR was released from the hybrid in both low pH condition (pH 1.2) and high pH condition (pH 7.4) fluids within 60 min. Compared with the conventional tablet form, approximately 4-times more CLR was released within 1 h at high pH conditions, indicating suitable local therapeutic performance. Therefore, Helicobacter pylori, which is located only in the gastric mucosal layer could be a good target organism for this hybrid. In conclusion, smectite could be a suitable carrier for local delivery of intercalated drug, and CLR intercalated smectite could be a new option for local therapy of gastrointestinal conditions.",
author = "Donghoon Chung and Song, {Young Goo} and Kang, {Il Mo} and Woohyun Choi and Changyun Park and Song, {Yun Goo}",
year = "2018",
month = "11",
day = "1",
doi = "10.1088/2053-1591/aadf08",
language = "English",
volume = "5",
journal = "Materials Research Express",
issn = "2053-1591",
publisher = "IOP Publishing Ltd.",
number = "11",

}

Development and characterization of clarithromycin-smectite hybrid for burst release at high pH condition. / Chung, Donghoon; Song, Young Goo; Kang, Il Mo; Choi, Woohyun; Park, Changyun; Song, Yun Goo.

In: Materials Research Express, Vol. 5, No. 11, 115408, 01.11.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and characterization of clarithromycin-smectite hybrid for burst release at high pH condition

AU - Chung, Donghoon

AU - Song, Young Goo

AU - Kang, Il Mo

AU - Choi, Woohyun

AU - Park, Changyun

AU - Song, Yun Goo

PY - 2018/11/1

Y1 - 2018/11/1

N2 - In this study, we developed and characterized a clarithromycin (CLR)-intercalated smectite hybrid and demonstrate that it holds great potential as an effective drug-carrier for local delivery of CLR. The intercalation of CLR into a smectite interlayer was examined at 0.4-4.0 mg ml -1 of CLR solution at pH 5. The developed CLR-intercalated smectite hybrid was characterized using x-ray diffraction (XRD), UV-vis spectroscopy, energy dispersive x-ray spectroscopy (EDS), thermogravimetric-differential thermal analysis (TG-DTA) and Fourier transform infrared spectroscopy (FT-IR). Intercalation of CLR was confirmed by an increase in the d-spacing in the XRD pattern and the ether absorbance band in the FT-IR spectrum for the CLR hybrid. An in vitro release study demonstrates that most of the CLR was released from the hybrid in both low pH condition (pH 1.2) and high pH condition (pH 7.4) fluids within 60 min. Compared with the conventional tablet form, approximately 4-times more CLR was released within 1 h at high pH conditions, indicating suitable local therapeutic performance. Therefore, Helicobacter pylori, which is located only in the gastric mucosal layer could be a good target organism for this hybrid. In conclusion, smectite could be a suitable carrier for local delivery of intercalated drug, and CLR intercalated smectite could be a new option for local therapy of gastrointestinal conditions.

AB - In this study, we developed and characterized a clarithromycin (CLR)-intercalated smectite hybrid and demonstrate that it holds great potential as an effective drug-carrier for local delivery of CLR. The intercalation of CLR into a smectite interlayer was examined at 0.4-4.0 mg ml -1 of CLR solution at pH 5. The developed CLR-intercalated smectite hybrid was characterized using x-ray diffraction (XRD), UV-vis spectroscopy, energy dispersive x-ray spectroscopy (EDS), thermogravimetric-differential thermal analysis (TG-DTA) and Fourier transform infrared spectroscopy (FT-IR). Intercalation of CLR was confirmed by an increase in the d-spacing in the XRD pattern and the ether absorbance band in the FT-IR spectrum for the CLR hybrid. An in vitro release study demonstrates that most of the CLR was released from the hybrid in both low pH condition (pH 1.2) and high pH condition (pH 7.4) fluids within 60 min. Compared with the conventional tablet form, approximately 4-times more CLR was released within 1 h at high pH conditions, indicating suitable local therapeutic performance. Therefore, Helicobacter pylori, which is located only in the gastric mucosal layer could be a good target organism for this hybrid. In conclusion, smectite could be a suitable carrier for local delivery of intercalated drug, and CLR intercalated smectite could be a new option for local therapy of gastrointestinal conditions.

UR - http://www.scopus.com/inward/record.url?scp=85053326612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053326612&partnerID=8YFLogxK

U2 - 10.1088/2053-1591/aadf08

DO - 10.1088/2053-1591/aadf08

M3 - Article

VL - 5

JO - Materials Research Express

JF - Materials Research Express

SN - 2053-1591

IS - 11

M1 - 115408

ER -